Huawei previews WATCH D3 blood-pressure monitor at ESC Congress 2026

Huawei has previewed the HUAWEI WATCH D3 in Munich ahead of its full launch, positioning the next-generation wearable as a more capable wrist-based ambulatory blood-pressure monitor. The early appearance took place alongside ESC Congress 2026, but the important details — price, full specifications and launch date — are still being kept behind the curtain.

What’s actually going on: Huawei showcased the HUAWEI WATCH D3 on 30 August in Munich, Germany, before a Huawei Innovative Product Launch scheduled for 2 September. The company describes it as the latest generation of its WATCH D blood-pressure monitoring line, following the HUAWEI WATCH D in 2021 and HUAWEI WATCH D2 in 2024.

Huawei says the HUAWEI WATCH D3 has been certified under the European Union’s CE MDR framework. The company says the certification covers single blood-pressure measurements, ambulatory blood-pressure monitoring and measurements taken before and after exercise.

The release also claims that the watch can measure blood pressure at elevated heart rates, record data before and after exercise and provide recommendations about suitable exercise intensity. Huawei says the device will add reminders for blood-pressure checks in high-altitude environments and during sudden temperature changes.

The watch is expected to receive refinements to its thickness and strap weight for more comfortable extended wear. Huawei says it will be available in three colour options inspired by “nature’s healing”. Further Health Glance metrics, health studies, sleep tracking and emotional-wellbeing features are also promised, although the company has not yet detailed every application.

Why you should care: blood-pressure monitoring is one of the more meaningful uses for a wearable, particularly when it can collect readings over time rather than relying on a single spot check. The D3’s claimed pre- and post-exercise measurements could make it more useful for people tracking how activity affects their readings, but the quality of those readings and the practical limits of the recommendations will need independent testing.

Huawei’s own release says data collected by Health Glance and health studies is for reference only and should not be used for diagnosis or treatment. CE MDR certification is not a guarantee that every feature is suitable for every person, and the watch should not replace advice or monitoring from a qualified medical professional.

Huawei has not announced the HUAWEI WATCH D3’s official launch date, price or complete specifications. Those details are expected through the company’s official channels after the 2 September product event.

Our opinion

The HUAWEI WATCH D3 is potentially one of Huawei’s more useful wearables, because blood pressure is a lot more consequential than another novelty watch face. But this is still a preview, not proof that the device will deliver medical-grade results in everyday use. We will reserve judgement until Huawei publishes the price, availability and full certification details — and independent testing gets a chance to interrogate the claims.